August J. Troendle sold $7.1M of Medpace (MEDP)

Executed Aug 12, disclosed Aug 14, 2 days later.

Value, as filed

$7.1M

11,824 sh across 2 lots

Executed

Aug 12

the trade date, as filed

Disclosed

Aug 14

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

August J. Troendle President & CEO profile →

August J. Troendle (President & CEO) filed 20 Form 4 reports in the trailing twelve months (0 purchases, 20 sales), most often in Medpace Holdings, Inc. (MEDP). The largest single filing was $62.0M of MEDP (101,417 sh across 2 lots, as filed), executed Nov 24 2025.

The name

MEDP

Medpace Holdings, Inc. MEDP · Healthcare · 60 filings in 24 months ticker →

Healthcare · Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by August J. Troendle in MEDP

MEDPSALE Medpace Holdings, Inc. $30.3M
48,667 sh across 2 lots
Exec Sep 29
Filed Oct 1 · 5:43 PM ET MEDPSALE Medpace Holdings, Inc. $1.5M
2,410 sh × $620.07
Exec Sep 28
Filed Sep 29 · 4:13 PM ET MEDPSALE Medpace Holdings, Inc. $44.4M
70,901 sh across 2 lots
Exec Sep 21
Filed Sep 23 · 4:05 PM ET MEDPSALE Medpace Holdings, Inc. $6.7M
10,880 sh × $620.40
Exec Sep 17
Filed Sep 21 · 4:23 PM ET MEDPSALE Medpace Holdings, Inc. $15.4M
24,741 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 4:39 PM ET MEDPSALE Medpace Holdings, Inc. $403K
650 sh × $620.27
Exec Aug 27
Filed Aug 31 · 4:11 PM ET MEDPSALE Medpace Holdings, Inc. $2.9M
4,673 sh across 2 lots
Exec Aug 25
Filed Aug 27 · 4:12 PM ET MEDPSALE Medpace Holdings, Inc. $10.0M
15,978 sh across 2 lots
Exec Aug 21
Filed Aug 25 · 4:24 PM ET